SPI
16 598,86
|
-30,25
|
-0,18 %
|
Analysen zu SPI-Werten
12.02.24 | ams-OSRAM Buy | Jefferies & Company Inc. | |
09.02.24 | Swiss Re Equal Weight | Barclays Capital | |
09.02.24 | UBS Underweight | Barclays Capital | |
09.02.24 | ams-OSRAM Buy | Jefferies & Company Inc. | |
09.02.24 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
08.02.24 | Zurich Insurance Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
08.02.24 | UBS Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
07.02.24 | ABB Hold | Jefferies & Company Inc. | |
07.02.24 | Novartis Buy | Deutsche Bank AG | |
07.02.24 | UBS Buy | Deutsche Bank AG | |
07.02.24 | UBS Overweight | JP Morgan Chase & Co. | |
07.02.24 | UBS Outperform | RBC Capital Markets | |
07.02.24 | Novartis Neutral | JP Morgan Chase & Co. | |
06.02.24 | Novartis Underweight | Barclays Capital | |
06.02.24 | UBS Underweight | Barclays Capital | |
06.02.24 | ABB Hold | Deutsche Bank AG | |
06.02.24 | UBS Overweight | JP Morgan Chase & Co. | |
06.02.24 | Novartis Buy | UBS AG | |
06.02.24 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
05.02.24 | Roche Sell | Deutsche Bank AG | |
05.02.24 | Novartis Buy | Jefferies & Company Inc. | |
05.02.24 | Roche Neutral | UBS AG | |
02.02.24 | ABB Sector Perform | RBC Capital Markets | |
02.02.24 | Roche Kaufen | DZ BANK | |
02.02.24 | Roche Equal Weight | Barclays Capital | |
02.02.24 | Roche Sell | Deutsche Bank AG | |
02.02.24 | ABB Hold | Deutsche Bank AG | |
02.02.24 | Novartis Buy | Deutsche Bank AG | |
01.02.24 | ABB Kaufen | DZ BANK | |
01.02.24 | Roche Neutral | UBS AG | |
01.02.24 | ABB Sector Perform | RBC Capital Markets | |
01.02.24 | Roche Underweight | JP Morgan Chase & Co. | |
01.02.24 | ABB Neutral | JP Morgan Chase & Co. | |
01.02.24 | ABB Market-Perform | Bernstein Research | |
01.02.24 | Roche Hold | Jefferies & Company Inc. | |
01.02.24 | ABB Neutral | UBS AG | |
31.01.24 | Novartis Kaufen | DZ BANK | |
31.01.24 | DocMorris Buy | Jefferies & Company Inc. | |
31.01.24 | Novartis Buy | UBS AG | |
31.01.24 | Novartis Buy | Jefferies & Company Inc. |